S

Sarah L. DeVos

Denali Therapeutics (United States)

ORCID: 0000-0003-0921-1763

Publishes on Alzheimer's disease research and treatments, Neuroinflammation and Neurodegeneration Mechanisms, Neuroscience and Neuropharmacology Research. 64 papers and 7.3k citations.

PubIndex Score99Top 1% · mid-careerHow it's scored

64Publications

7.3kTotal Citations

First publication: 1993First senior author: 2017

Alzheimer's disease research and treatments Neuroinflammation and Neurodegeneration Mechanisms Neuroscience and Neuropharmacology Research Prion Diseases and Protein Misfolding Dementia and Cognitive Impairment Research

Top publicationsby citations

Tau Protein Disrupts Nucleocytoplasmic Transport in Alzheimer’s Disease

Bahareh Eftekharzadeh, Bradley T. Hyman, J. Gavin Daigle et al.|Neuron|2018

Cited by 461

Neuronal uptake and propagation of a rare phosphorylated high-molecular-weight tau derived from Alzheimer’s disease brain

Shuko Takeda, Bradley T. Hyman, Susanne Wegmann et al.|Nature Communications|2015

Cited by 378

Antisense Reduction of Tau in Adult Mice Protects against Seizures

Sarah L. DeVos, Timothy M. Miller|Journal of Neuroscience|2013

Cited by 312

Synaptic Tau Seeding Precedes Tau Pathology in Human Alzheimer's Disease Brain

Sarah L. DeVos, Bradley T. Hyman, Bianca T. Corjuc et al.|Frontiers in Neuroscience|2018

Cited by 311

The role of microglia in processing and spreading of bioactive tau seeds in Alzheimer’s disease

Sarah C. Hopp, Bradley T. Hyman, Yang Lin et al.|Journal of Neuroinflammation|2018

Cited by 294